SYRE 144 DEF-14A Report Nov. 3, 2025 | Alphaminr
Spyre Therapeutics, Inc.

SYRE 144 Report ended Nov. 3, 2025

SPYRE THERAPEUTICS, INC.
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
CIK: 1636282
Filing Type: 144
Report Date: 2025-11-03
Download URL: https://www.sec.gov/Archives/edgar/data/1636282/000195004725008390/xsl144X01/primary_doc.xml
]]>
TABLE OF CONTENTS